insights_auto
Waarom is ALMKT gedaald 4,28%?
Meer informatiechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€ 0,087
arrow_downward
-4,28%(-0,0039) 1D
17 nov, 14:24:52 GMT+1 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ALMKT genereren…
Openen
€ 0,09
Hoog
€ 0,09
Laag
€ 0,09
Beursw.
17,27 mln.
Gem. vol.
478,35K
Volume
235,31K
Koers/winst-verhouding
0,74
52 wk hoog
€ 0,23
52 wk laag
€ 0,07
WPA
€ 0,12
Uitstaande aandelen
195,26 mln.
Aantal medewerkers
56
Openen
€ 0,09
Hoog
€ 0,09
Laag
€ 0,09
Beursw.
17,27 mln.
Gem. vol.
478,35K
Volume
235,31K
Koers/winst-verhouding
0,74
52 wk hoog
€ 0,23
52 wk laag
€ 0,07
WPA
€ 0,12
Uitstaande aandelen
195,26 mln.
Aantal medewerkers
56
Nieuwsartikelen
Van webbronnen en nieuwspartners
FOREX.com
·
31 minuten geleden
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Quartz
·
50 minuten geleden
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
Investor's Business Daily
·
41 minuten geleden
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Zawya
·
33 minuten geleden
Wells Fargo sets 2027 S&P 500 target at 8,200, favors hyperscalers as AI trade matures
Profiel
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Over Mauna Kea Technologies SA
CEOSacha Loiseau
Medewerkers56
Opgericht2000
Hoofdkantoor-
SectorHealth Care
Industrie-
Websitemaunakeatech.com